FASN and metabolic dysfunction-associated steatotic liver disease: We found that miR-103-3p regulates the mRNA levels and protein expression of the key enzymes for fatty acid synthesis (FASN and ACSL1) and the oxidation and decomposition of fatty acids (ACOX1) to alleviate liver tissue lesions in NAFLD.